Bone tumors Flashcards

1
Q

What is the usual clinical presentation of a bone tumor?

A

usually nonspecific, may present;

  • pain (e.g. osteoid osteoma= severe pain, worse at night, relieved by aspirin)
  • mass (e.g. parosteal osteosarcoma= painless, hard growing mass in popliteal fossa)
  • pathologic fracture
  • asymptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the most common bone tumors in children? young adults? elderly?

A
  • children, adolescents= osteosarcoma, Ewing’s sarcoma
  • young adults= giant cell tumor
  • elderly= chondrosarcoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What can the radiological pattern of a bone tumor tell you?

A
  • margins= growth rate
    • sclerotic margin is generally an indication of benign, slowly growing neoplasm (there is time for bone growth to happen around the lesion)
    • ill-defined margin is generally an indication of malignant, rapidly growing neoplasm
  • solid, ivory-like pattern is generally seen in malignant bone matrix forming tumors
  • “rings and arcs” are generally seen in chondroid matrix forming tumors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe an osteoid osteoma

A
  • long bones (femur, tibia)
  • < 2 cm
  • night pain
  • responds to aspirin
  • radiolucent lesions within sclerotic cortex (clear ring around lesion -> slow growing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe an osteoblastoma

A
  • vertebrae or long bone metaphysis
  • > 2 cm
  • painful but NOT responsive to aspirin
  • expansile radiolucency with mottling (less defined borders -> faster growing)
  • Look like osteoid osteoma (Circumscribed benign lesion within bone) **Area of immature bone being formed by osteoblasts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the prevalence of bone forming (osteogenic) tumors?

A
  • relatively rare group of tumors (compared to carcinomas and hematopoietic tumors)
    • malignant bone tumors comprise ~0.2% of all types of cancer
  • they represent and important percentage of potentially curable cancers following multimodal therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the prevalence of osteosarcoma?

A
  • most common sarcoma of bone (35%)
    • ~2000 new cases per year in the US
    • 26% chondrosarcoma, 16% Ewing, 8% chordoma, 6% MFH
  • bimodal age distribution, M>F
    • ​mean age= 15 yo (60% of cases 10-20)
    • 2nd peak in ages 55-80
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where are osteosarcomas commonly found?

A
  • malignant mesenchymal tumor in which cells produce osteoid or bone
  • most common in the metaphysis of long bones
    • esp. femur, tibia, humerus
    • seen in flat bones/spine in older patients
  • hematogenous spread to lungs is common and happens early in the cancer progression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the pathogenesis of osteosarcoma?

A

Several factors increase osteosarcoma risk;

  • inherited mutant allele of RB (retinoblastoma) gene
  • mutation of p53 suppressor gene causing Li-Fraumeni
    • increased risk of bone/soft tissue sarcomas, early onset breast cancer, brain tumors, leukemia
  • overexpression fo MDM2 (5-10%), INK4 and p16
  • sites of bone growth/disease (i.e. Paget disease)
  • prior irradiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the clinical/radiological findings of an osteosarcoma? How do you treat it?

A
  • infiltrative tumor, extending into soft tissue
  • malignant cells producing osteoid

**treat with neo-adjucant chemotherapy and surgical resection (poor prognosis before the development of chemotherapy, now 60-65% 3-5 yr survivial for patients without metastasis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe an osteochondroma

A
  • most common benign tumor of bone
  • common in metaphysis of long bones
  • malignant transformation is rare (<1%) but increased risk (~40%) in hereditary multiple exostoses (multiple osteochondromas)
    • autosomal dominant, most commonly secondary to mutations in EXT-1 (8q24)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Descibe an enchondroma

A
  • benign hyaline cartilage lesion (intramedullary chondroma)
  • usually asymptomatic, incidental finding
  • appendicular skelton (esp small bones of hands and feet)
  • X-rays; lytic, lobulated, corical thinning
  • Micro; lobules of hyaline carilage, minimal atypia
  • Treatment; none unless lesions shows changes (onset of pain= evidence of malignancy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe two types of multiple chondromatoses

A

**both common point mutations in IDH1 or IDH2

  • Ollier disease
    • multiple enchondromata
    • tend to have regional distribution
    • may or may not have severe skeletal malformation
  • Maffucci syndrome
    • multiple enchondromata + angiomata
    • severe skeletal malformation
    • higher incidence of malignant transformation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the prevalence of chondrosarcomas

A
  • second (after osteosarcomas) most common bone sarcoma (26%)
  • wide range of ages, mainly older adults (above 40-50 yo)
    • peak during 6th/7th decades
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where are chondrosarcomas often located?

A
  • central skeleton; pelvis and ribs (45%)
  • humerus/femur (metaphysis or diaphysis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the common characteristics of chondrosarcomas grossly/on imaging?

A
  • medullary location, cortical erosion or destruction
  • frequently contain calcifications, “popcorn like”
  • occasional soft tissue extension (not as aggressive as osteosarcoma)
  • generally more cellular and nuclei more pleomorphic than enchondromas
    • binucleation is frequent, but doesn’t suffice for malignant diagnosis
17
Q

Describe the grading system for chondrosarcomas

A
  • grade 1= more matrix than cells (though a little more than normal)
  • grade 2= more atypia, focal areas of increased dense cellularity
  • grade 3= even more atypia and mitotic figures (more aggressive but less common)
18
Q

What is the prognosis for chondrosarcomas? What are some observed variants?

A
  • 5 year survival
    • grades 1,2= 80-90%
    • grade 3= 29% (pulmonary metastasis)
  • Variants;
    • de-differentiated (look like embryonic tissue)
    • myxoid
    • clear cell
    • mesenchymal
    • juxtacortical
19
Q

Describe a non-ossifying fibroma

A
  • common developmental benign cortical defect
    • 1 in every 4 individuals
    • multifocal in 25% of cases
  • tibia, femur (metaphysis) 1st-3rd decades
    • incidental finding or pathological fracture
  • eccentric, lytic, peripheral sclerosis (slow growing)
20
Q

Describe fibrous dysplasia

A
  • developmental arrest of bone
  • monostotic (one site)
    • most common, seen in adolescents
    • ribs, mandible, femur
  • polyostotic (multiple sites)
    • infancy/childhood
    • crippling deformities, craniofacial involvement common
  • e.g. McCune-Albright syndrome
21
Q

Describe McCune-Albright syndrome

A
  • polyostotic fibrous dysplasia with endocrinopathies and cafe au lait spots
    • sexual precocity, acromegaly, Cushing syndrome
  • rare form; F>M
  • activating germline mutations of GNAS (GTP binding protein) result in excess cAMP leading to endocrine gland hyperfunction
22
Q

Describe the pathology and treatment of fibrous dysplasia

A

Pathology;

  • haphazard, curvilinear, randomly oriented woven bone trabeculae (“Chinese characters”), surrounded by fibroblastic stroma
  • no significant osteoblastic rimming

**Treat conservatively, except the polyostotic form

23
Q

Describe Ewing Sarcoma

A

**PNET (primitive neuroectodermal tumor)

  • second most common malignant bone tumoe in childhood
  • adolescents, young adults, M>F
  • present as painful, often enlarging masses
  • found in diaphysis of long tubular bones (ribs, pelvis)
24
Q

Describe the appearance of Ewing Sarcoma grossly/on imaging

A
  • destructive moth-eaten, permeative medullary lesion with large soft tissue mass
  • “onion skin” pattern of periosteal reaction in response to rapid growth
  • hemorrhage and necrosis common
25
Q

Describe the appearance of Ewing Sarcoma on histology

A
  • sheets of primitive small round blue cells with primitive neural phenotype (“rosettes”)
  • membranous CD99
  • contain abundant glycogen
26
Q

What is the pathogenesis and treatment of Ewing sarcoma?

A

Pathogenesis:

  • EWS protein involved in >95% of ES/PNET
  • t(11,22) present in 85% of tumors
    • EWS gene on 22q fused with FLI-1 transcription factor on 11q

**Treat with chemo/surgery, radiation may be added (stage 1= 5 year survival 70% with chemo/RT)

27
Q

Describe the prevalence and common location of giant cell tumors

A
  • young adults (20-40 yo), older adolescents (skeletally mature), F>M
  • epiphyseal location (knee, proximal humerus, radius)
  • most are benign, locally aggressive (may destroy cortex of bone and extend into soft tissue)
28
Q

Describe metastatic bone tumors

A
  • most common malinant bone tumor, especially in adults (20x more frequent than primary bone tumors)
  • mostly multiple; solitary lesions may mimic a primary bone tumor and precede discovery of its source
    • 70% go to axial skeleton (skull, ribs, vertebrae, sacrum)
    • mostly lytic
    • may be blastic (bone forming); breast, prostate
  • 80% come from “BLT-KP”
    • breast, lung, thyroid, prostate, and kidney